References
- Schoenfield LJ. Manifestations of cholelithiasis. In: Schoenfield LJ. Diseases of the gallbladder and biliary system. New York: J Wiley, 1977:108–69
- Glenn F. Trends in surgical treatment of calculous disease of the biliary tract. Surg Gynecol Obstet 1975:140:877–84
- Trotman BW, Soloway RD. Pigment vs. cholesterol cholelithiasis: clinical and epidemiologic aspects. Am J Dig Dis 1975:20:735–9
- Holan KR, Holzbach T, Hermann RE, et al. Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease. Gastroenterology 1979:77:611–7
- Danzinger RG, Hofmann AF, Schoenfield LJ, et al. Dissolution of cholesterol gallstones by chenodeoxycholic acid. N Engl J Med 1972:286:1–8
- Hofmann AF, Thistle JL. Efficacy and specificity of chenodeoxycholic acid for dissolving gallstones. J Clin Invest 1973:52:48a
- Bell GD, Whitney B, Dowling RH. Gallstone dissolution in man using chenodeoxycholic acid. Lancet 1973:1:1213–6
- Tangedahl TN, Carey WD, Hightower NC, et al. Drug and treatment efficacy of chenodeoxycholic acid in patients with cholelithiasis and increased surgical risk. (Submitted for publication)
- Schoenfield LJ, Lachin JM, Steering Committee of the National Cooperative Gallstone Study Group. Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: The National Cooperative Gallstone Study, a controlled trial of efficacy and safety. Ann Intern Med 1981:95:257–82
- Grimm RH Jr, Leon AS, Hunninghake DB, et al. Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients: a double blind controlled trial. Ann Intern IV ed 1981:94:7–11
- Newman HF, Northup JD, Rosenblum M, et al. Complications of cholelithiasis. Am J Gastroenterol 1968:50:476–96
- Grade WA, Ransohoff DF. The natural history of silent gallstones: the innocent gallstone is not a myth. (Abstr) Gastroenterology 1981:80(pt 2):1161
- Lund J. Surgical indications in cholelithiasis. Ann Surg 1960:151:153–62
- Tucker LE, Tangedahl TN, Newmark SR. Prevalence of gallstones in obese Caucasian American women. Int J Obes (in press)
- Iser JH, Maton PN, Murphy GM, et al. Resistance to chenodeoxycholic acid (CDCA) treatment in obese patients with gallstones. Br Med J 1978:1:1509–12
- Maton PN, Murphy GM, Dowling RH. Lack of response to chenodeoxycholic acid in obese and nonobese patients. Gut 1980:21:1082–6
- Mundth ED. Cholecystitis and diabetes mellitus. N Engl J Med 1962:267:642–6
- Mok HY, Bell GD, Dowling RH. Effect of differing doses of chenodeoxycholic acid on bile lipid composition and on frequency of side effects in patients with gallstones. Lancet 1974:2:253–7
- Thistle JL, Yu PY, Hofmann AF, et al. Prompt return of bile to supersaturated state followed by stone recurrence after discontinuation of chenodeoxycholic acid therapy. Gastroenterology 1974:66:789